Genocea Biosciences (GNCA)

Genocea Biosciences (GNCA) Cash flow


Genocea Biosciences Cash Flow

GNCA's free cash flow for Q was $-16.17M. For the fiscal year, GNCA's free cash flow was decreased by $-4.42M and operating cash flow was $-15.21M. See a summary of the company’s cash flow.
Cash Flow
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -48.19M$ -45.37M$ -41.65M$ -37.73M$ -41.23M$ -47.60M
Investing Cash Flow
$ -3.10M$ -3.21M$ -2.56M$ -1.09M$ -131.00K$ 34.91M
Financing Cash Flow
$ 5.39M$ 5.96M$ 83.85M$ 52.90M$ 55.45M$ -2.46M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 169.12M$ 37.78M$ 80.40M$ 40.76M$ 26.68M$ 12.59M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
$ 547.00K$ 583.00K$ 1.05M$ 1.10M$ 1.07M$ 1.19M
Issuance Of Capital Stock
$ 7.75M$ 11.35M$ 83.84M$ 54.67M$ 55.46M$ 246.00K
Issuance Of Debt
-$ 10.00M$ 0.00$ 0.00$ 592.00K$ 0.00
Repayment Of Debt
$ -2.50M$ -15.23M$ -134.00K$ -1.92M$ -535.00K$ -3.15M
Free Cash Flow
$ -51.33M$ -48.66M$ -44.24M$ -38.87M$ -41.48M$ -48.78M
Domestic Sales
Foreign Sales
Currency in USD

Genocea Biosciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis